Cargando…
Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
BACKGROUND: Non-diabetic overweight/obese metabolic dysfunction-associated fatty liver disease (MAFLD) represents the largest subgroup with heterogeneous liver fibrosis risk. Metabolic dysfunction promotes liver fibrosis. Here, we investigated whether incorporating additional metabolic risk factors...
Autores principales: | Lee, Chi-Ho, Lui, David Tak-Wai, Li, Raymond Hang-Wun, Yuen, Michele Mae-Ann, Fong, Carol Ho-Yi, Leung, Ambrose Pak-Wah, Chu, Justin Chiu-Man, Mak, Loey Lung-Yi, Lam, Tai-Hing, Woo, Jean, Woo, Yu-Cho, Xu, Aimin, Tse, Hung-Fat, Tan, Kathryn Choon-Beng, Cheung, Bernard Man-Yung, Yuen, Man-Fung, Lam, Karen Siu-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853017/ https://www.ncbi.nlm.nih.gov/pubmed/36686469 http://dx.doi.org/10.3389/fendo.2022.1056562 |
Ejemplares similares
-
Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective Study
por: Chow, Wing Sun, et al.
Publicado: (2013) -
Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus
por: Lee, Chi Ho, et al.
Publicado: (2017) -
Long-term clinical outcomes of drug-eluting stents vs. bare-metal stents in Chinese geriatric patients
por: Chan, Pak-Hei, et al.
Publicado: (2013) -
Screening strategy for non-alcoholic fatty liver disease
por: Zhang, Saisai, et al.
Publicado: (2023) -
Fear of COVID-19 and its associations with perceived personal and family benefits and harms in Hong Kong
por: Sit, Shirley Man-Man, et al.
Publicado: (2021)